INS and diabetes mellitus: In fact, it must be pointed out that despite the newer antidiabetic therapeutic strategies, almost 30% of patients with T2D are currently treated with insulin because the duration of diabetes is still a strong, independent determinant of insulin use, still lacking disease-modifying drugs [46,47].